These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18563292)

  • 41. Purinoceptors evoke different electrophysiological responses in pancreatic ducts. P2Y inhibits K(+) conductance, and P2X stimulates cation conductance.
    Hede SE; Amstrup J; Christoffersen BC; Novak I
    J Biol Chem; 1999 Nov; 274(45):31784-91. PubMed ID: 10542200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nucleotide receptors.
    North RA; Barnard EA
    Curr Opin Neurobiol; 1997 Jun; 7(3):346-57. PubMed ID: 9232809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. P2 purinoceptors and pyrimidinoceptors of catecholamine-producing cells and immunocytes.
    Illes P; Nieber K; Fröhlich R; Nörenberg W
    Ciba Found Symp; 1996; 198():110-25; discussion 125-9. PubMed ID: 8879821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
    Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
    J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coexpression of functional P2X and P2Y nucleotide receptors in single cerebellar granule cells.
    Hervás C; Pérez-Sen R; Miras-Portugal MT
    J Neurosci Res; 2003 Aug; 73(3):384-99. PubMed ID: 12868072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropharmacology of purinergic receptors in human submucous plexus: Involvement of P2X₁, P2X₂, P2X₃ channels, P2Y and A₃ metabotropic receptors in neurotransmission.
    Liñán-Rico A; Wunderlich JE; Enneking JT; Tso DR; Grants I; Williams KC; Otey A; Michel K; Schemann M; Needleman B; Harzman A; Christofi FL
    Neuropharmacology; 2015 Aug; 95():83-99. PubMed ID: 25724083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. UDP facilitates microglial phagocytosis through P2Y6 receptors.
    Inoue K
    Cell Adh Migr; 2007; 1(3):131-2. PubMed ID: 19262132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain.
    Kobayashi K; Yamanaka H; Fukuoka T; Dai Y; Obata K; Noguchi K
    J Neurosci; 2008 Mar; 28(11):2892-902. PubMed ID: 18337420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
    Tomé AR; Castro E; Santos RM; Rosário LM
    BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Purinergic signaling and microglia.
    Färber K; Kettenmann H
    Pflugers Arch; 2006 Aug; 452(5):615-21. PubMed ID: 16791619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuron-microglia interaction by purinergic signaling in neuropathic pain following neurodegeneration.
    Tsuda M; Inoue K
    Neuropharmacology; 2016 May; 104():76-81. PubMed ID: 26327676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrophysiological effects of ATP on brain neurones.
    Illes P; Nieber K; Nörenberg W
    J Auton Pharmacol; 1996 Dec; 16(6):407-11. PubMed ID: 9131427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Purinergic modulation of microglial cell activation.
    Sperlágh B; Illes P
    Purinergic Signal; 2007 Mar; 3(1-2):117-27. PubMed ID: 18404425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The regulation of osteoblast function and bone mineralisation by extracellular nucleotides: The role of p2x receptors.
    Orriss IR; Key ML; Brandao-Burch A; Patel JJ; Burnstock G; Arnett TR
    Bone; 2012 Sep; 51(3):389-400. PubMed ID: 22749889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purinergic signalling--an overview.
    Burnstock G
    Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization.
    Gerevich Z; Zadori Z; Müller C; Wirkner K; Schröder W; Rubini P; Illes P
    Br J Pharmacol; 2007 May; 151(2):226-36. PubMed ID: 17351651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Introduction to purinergic signalling in the brain.
    Burnstock G
    Adv Exp Med Biol; 2013; 986():1-12. PubMed ID: 22879061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purinergic system, microglia and neuropathic pain.
    Tsuda M; Tozaki-Saitoh H; Inoue K
    Curr Opin Pharmacol; 2012 Feb; 12(1):74-9. PubMed ID: 22036170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ATP selectively suppresses the synthesis of the inflammatory protein microglial response factor (MRF)-1 through Ca(2+) influx via P2X(7) receptors in cultured microglia.
    Kaya N; Tanaka S; Koike T
    Brain Res; 2002 Oct; 952(1):86-97. PubMed ID: 12363408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purinergic receptor-mediated morphological changes in microglia are transient and independent from inflammatory cytokine release.
    McIlvain HB; Ma L; Ludwig B; Manners MT; Martone RL; Dunlop J; Kaftan EJ; Kennedy JD; Whiteside GT
    Eur J Pharmacol; 2010 Sep; 643(2-3):202-10. PubMed ID: 20621081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.